MediWound (MDWD) Share-based Compensation (2013 - 2025)
MediWound's (MDWD) quarterly Share-based Compensation came in at $662000.0 in Q4 2025, down 19.46% year-on-year from $822000.0 in Q4 2024, and down 10.54% quarter-over-quarter from $740000.0 in Q3 2025.
MediWound (MDWD) Share-based Compensation (2013 - 2025) Analysis & Trends
MediWound's Share-based Compensation history runs 13 years deep, the most recent figure standing at $662000.0 for Q4 2025.
- On a quarterly basis, Share-based Compensation fell 19.46% year-over-year to $662000.0 in Q4 2025; TTM through Dec 2025 was $3.1 million, a 0.96% decrease from a year earlier, with the FY2025 full-year figure at $3.1 million, down 0.96% from the prior year.
- Share-based Compensation retreated to $662000.0 in Q4 2025 per MDWD's latest filing, from $740000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $1.0 million in Q3 2024 and bottomed at $252000.0 in Q2 2022.
- The 5-year median for Share-based Compensation is $630500.0 (2022), against an average of $590250.0.
- Across the five-year window, Share-based Compensation sank 56.01% in 2023 and jumped 236.33% in 2024, its largest moves.
- Year by year, Share-based Compensation stood at $390000.0 in 2021, then soared by 64.62% to $642000.0 in 2022, then sank by 53.58% to $298000.0 in 2023, then soared by 175.84% to $822000.0 in 2024, then slipped by 19.46% to $662000.0 in 2025.
- Per Business Quant, the three latest MDWD Share-based Compensation figures stand at $662000.0 (Q4 2025), $740000.0 (Q3 2025), and $862000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9.26 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.18 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 87.30 Mn |
| 10 | MediWound | 183.16 Mn | 178.36 Mn | 278,000.00 | 662,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 662,000.00 |
| Dec 31, 2025 | 662,000.00 |
| Sep 30, 2025 | 740,000.00 |
| Sep 30, 2025 | 740,000.00 |
| Jun 30, 2025 | 862,000.00 |
| Jun 30, 2025 | 862,000.00 |
| Mar 31, 2025 | 844,000.00 |
| Mar 31, 2025 | 844,000.00 |
| Dec 31, 2024 | 822,000.00 |
| Dec 31, 2024 | 822,000.00 |
| Sep 30, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 758,000.00 |
| Jun 30, 2024 | 758,000.00 |
| Mar 31, 2024 | 512,000.00 |
| Mar 31, 2024 | 512,000.00 |
| Dec 31, 2023 | 298,000.00 |
| Dec 31, 2023 | 298,000.00 |
| Sep 30, 2023 | 311,000.00 |
| Sep 30, 2023 | 311,000.00 |